N/A N=45 MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases
Rheumatic Diseases · Physician-Patient Relations · Contraception
Primary: Acceptability of Intervention — 4.45; 3.97 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=108 Pitocin or Oral Misoprostol for PROM IOL
PROM
Primary: Time From Induction of Labor (IOL) to Delivery — 18.1; 14.9 Hours
N/A N=37 Satisfaction With an In-house Developed Nasal Foreign Body Removal Manikin
Satisfaction · Consumer Satisfaction
Primary: Satisfaction Scores — 4; 4; 4; 4 score on a scale
N/A N=98 Developing an Implementation Strategy for Post-concussion Communication With Low Health Literacy Parents in the Emergency Department
Concussion, Brain
Primary: Change in Concussion Management Behaviors: Communication — 5.49; 6.71 Score on a scale — p=0.021
Phase 2 N=24 Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)
Degenerative Disc Disease · Intervertebral Disc Disease · Low Back Pain
Primary: Pain and Disability Evaluation — 0.28; 0.15 scores from 0 to 1
N/A N=39 HCV Seek, Test and Rapid Treatment for Young PWID
Hepatitis C · Drug Use
Primary: The Proportion of Participants Who Achieve Sustained Virologic Response 12 (SVR12) With Rapid Treatment Strategy Compared to Usual Care — 9; 1 Participants — p=.01
N/A N=42 Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding Assays
Malaria
Primary: Oocyst Prevalence — 5.2; 6.3; 2.3; 2.2 percentage of mosquitoes — p=0.711
N/A N=74 Telemedicine for PrEP Throughout Mississippi
HIV/AIDS
Primary: Number of Participants Who Attended One or More PrEP Telemedicine Appointments at 3 Months Post-intervention (Electronic Medical Record Extraction) — 8 Participants
N/A N=851 Behavioral Insights to Encourage Judicious Prescribing of Opioids
Substance-Related Disorders
Primary: Average Change Over Time in Dispensed Narcotics — 347.65; 350.09; 288.36; 318.60 Morphine milligram equivalents — p=<0.05
Phase 3 N=247 A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder
Major Depressive Disorder
Primary: The Frequency of Subjects With Treatment-Emergent Adverse Events (TEAEs) — 96.8; 93.1 percentage of participants
N/A N=95 Improving Rehabilitation Outcomes After Total Hip Arthroplasty
Total Hip Arthroplasty · Osteoarthritis
Primary: 6 Minute Walk Test (6MW) — 252.4; 207.0 meters
N/A N=63 Evaluation of Wear Experience With Daily Disposable and Monthly Replacement Toric Contact Lenses
Astigmatism Bilateral
Primary: Visual Analog Scale Survey of Overall Comfort — 71.6; 63.2 units on a scale
Phase 3 N=39,540 A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older
Covid19 · SARS-CoV-2
Primary: Number of Participants Who Experienced a First Episode of Virologically-confirmed {Reverse Transcription Polymerase Chain Reaction (RT-PCR) Positive} Case of COVID-19 of…
N/A N=30 Pharmacokinetics of Acetaminophen in Pediatric Patients With Congenital Heart Disease
Congenital Heart Disease
Primary: Acetaminophen Serum Concentrations — 19; 17; 13; 13 mcg/mL
N/A N=139 Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers
Cardiovascular Diseases · Heart Diseases · Hypertension
Primary: Change in Systolic Blood Pressure at One Year Among People Who Have Quit Smoking — -1.78; -0.17; -1.64 millimeters of mercury (mmHg)